Upcoming Events

Join pharma and biotech R&D leaders, top tech companies involved in clinical development and healthcare innovation, investigator sites, service companies, and the regulators from FDA at CNS Summit 2019.

The speakers are a big part of what makes the CNS Summit special, but it’s the community aspect that makes it extraordinary. Because the Summit was started by the R&D community, it’s the community and the collaborative format that offers you a unique opportunity to participate directly with like-minded individuals and make the important connections that you need to drive innovation and remain competitive.

Experience a community passionate about shaping the future, with a focus on collaboration, innovation, and technology Oct 31 – Nov 3 in Boca Raton, FL!

Register now

This year’s conference will provide a forum for participants to evaluate exemplar advanced primary care practices with proven results; collaborate face-to-face with leaders across diverse sectors who are advancing strategies to strengthen primary care; and join with colleagues advocating for payment and delivery reforms, including more investment in primary care.

Register now

“A ‘who’s who’ of AI in biopharma.”  

This event is where the industry’s top science minds, AI technology experts, and strategy leaders meet to share detailed use cases of AI in drug discovery, clinical development, and real-world evidence, in order to improve patients’ lives.

The AI Applications Summit is a new kind of collaborative experience where you can hear from an elite speaker line-up including representatives from Sanofi, Novartis Institutes for Biomedical Research, Pfizer, Biogen, AstraZeneca, GSK, Janssen, and more who are pioneers in the movement.

Agenda at a glance:

• Disrupting the status quo to find the right collaboration partner – focused on internal and external collaboration, featuring an open discussion around new collaboration models to impact patients in more meaningful ways.
• Real-world evidence – overcoming barriers to RWE adoption, realizing value, and finding the intersections between AI and RWE lie to better treat patients.
• Use cases presenting what has been learned by early adopters using AI in drug discovery.
• Unlocking the value of data – collecting the right kind of information and determining how ML/AI can be used to optimize it.
• AI for clinical development – improving success outcomes, realizing the potential of virtual and hybrid clinical trials, and lowering costs.

Click here to see the agenda.

Secure your place now and save 10% on the prevailing rate with code STAT10.

Register now

With innovations like the Apple Watch and FitBit coming to market wearable devices have become one of the trendiest accessories to hit the consumer world. With everyone from your uncle, to your little sister, and even to your grandmother wearing these devices the smart wearable device market is projected to double by 2022.

But what is the balance of function versus fashion for these devices? Have they made an impact — or have they been all hype?

Join the UMass Lowell innovation community, and Johnson and Johnson — JLABS as they bring together expert thought leaders in this space to discuss the true value and definition of “wearables devices” and “smart clothing”, the data that serves value to experts in the field, where these devices have fallen short in the past and can be improved in the future and the overall promise of the next generation of wearable devices.

Tours of the UMass Lowell Fabric Discovery Center will be available during networking.

Register now

The 15th Annual Personalized Medicine Conference at Harvard Medical School will explore the science, business, and policy issues facing personalized medicine as scientists refine their understanding of how groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data analytics, and digital health applications can empower both physicians and patients with information about how an expanded set of biological characteristics — including those found in the proteome and microbiome — may influence their health and their responses to increasingly impactful therapies.

Register now

The scientist-led conference on the future of brain and body health, with talks by: DARPA, FDA,  Harvard, MGH, MIT, Roche, Biogen, Tel Aviv University, Neurosteer, UnitedHealthcare, Brown, and the next unicorn startup/investor panel.

Register now

The Annual Summit on Life Sciences IP Due Diligence is a one-of-a-kind, interactive forum where top diligence experts will discuss best practices and strategies for executing a proper IP due diligence analysis, both for your own portfolio, and that of potential targets. STAT Plus readers are being given the unique opportunity to register for the event at 10% off with discount code: D10-657-657IX01

Attendees will benefit from in-depth sessions which will help them to:

• Identify criteria that impacts the overall value of the deal during the IP valuation process

• Conduct international legal risk assessments and find appropriate resources for IP due diligence examinations

• Find funding options to facilitate business expansion and accelerate growth

• Mitigate the inherent risks presented in life sciences IP due diligence investigations

• Negotiate and draft the relevant documents to ensure a detailed, robust, and accurate agreement

There will also be great opportunities to network and benchmark strategies with professionals from leading life sciences companies including Akeba Therapeutics, Alexion Pharmaceuticals, Celgene, Dana-Farber Cancer Institute, Novartis Institutes for BioMedical Research, and Stryker. STAT Plus readers, register at 10% with discount code: D10-657-657IX01

Register now

As health care spending continues its unsustainable rise, there is growing pressure to incentivize increased quality, and decreased costs. Value-based care models, which focus on the quality of care instead of the quantity of services, could address both of these issues. Shifting to a value-based approach, however, requires changes across the health care ecosystem—in financing and population health management as well as for payers and providers.

In this webinar, Joe Kimura, MD will discuss how a high-performing community-based nonprofit health system has systematically applied analytics to drive Population Health management and support value-based care.

Register now